Morgan Stanley Embecta Corp. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Embecta Corp. stock. As of the latest transaction made, Morgan Stanley holds 549,555 shares of EMBC stock, worth $6.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

549,555

Previous 975,066 43.64%

Holding current value

$6.71 Million

Previous $18.5 Million 60.49%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $5.26 Million - $8.23 Million	-425,511 Reduced 43.64%	549,555 $7.29 Million
Q4 2023 Feb 13, 2024	BUY	$12.87 - $19.09 $3.67 Million - $5.45 Million	285,337 Added 41.37%	975,066 $18.5 Million
Q3 2023 Nov 15, 2023	BUY	$15.0 - $22.17 $3.71 Million - $5.48 Million	247,356 Added 55.92%	689,729 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $1.82 Million - $2.59 Million	-84,436 Reduced 16.03%	442,373 $9.56 Million
Q1 2023 May 15, 2023	SELL	$23.07 - $32.77 $2.81 Million - $3.99 Million	-121,654 Reduced 18.76%	526,809 $14.8 Million

Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $1.45 Million - $2.04 Million	57,416 Added 9.71%	648,463 $16.4 Million
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $2.06 Million - $2.87 Million	85,943 Added 17.01%	591,047 $17 Million
Q2 2022 Oct 27, 2022	BUY	$24.78 - $33.36 $12.5 Million - $16.8 Million	503,960 Added 44052.45%	505,104 $12.8 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $12.5 Million - $16.8 Million	503,960 Added 44052.45%	505,104 $12.8 Million
Q1 2022 Oct 27, 2022	SELL	$33.33 - $47.0 $16.8 Million - $23.7 Million	-503,960 Reduced 99.77%	1,144 $38,000
Q1 2022 May 13, 2022	BUY	$33.33 - $47.0 $38,129 - $53,768	1,144 New	1,144 $38,000

Others Institutions Holding EMBC

# of Institutions

392

Shares Held

52.2M

Call Options Held

45.7K

Put Options Held

49K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $706M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account